These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2568420)

  • 1. Thermodynamics of the binding of salicylate to human serum albumin: evidence of non-competition with imidazole.
    Matias I; Ceballos A; Gonzalez-Velasco F; Cachaza JM
    J Pharm Pharmacol; 1989 Feb; 41(2):123-5. PubMed ID: 2568420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imidazole binding to human serum albumin.
    Rodrigo MC; Ceballos A; Mariño E; Cachaza JM; Domínguez-Gil A; Kuemmerle HP
    Int J Clin Pharmacol Ther Toxicol; 1988 Jun; 26(6):320-2. PubMed ID: 3410610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of salicylate binding to normal plasma by extracts of uremic fluids.
    Roman S; Gulyassy PF; Depner TA
    Am J Kidney Dis; 1984 Sep; 4(2):153-61. PubMed ID: 6475946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of temperature on the binding of salicylate by human serum albumin.
    Zaroslinski JF; Keresztes-Nagy S; Mais RF; Oester YT
    Biochem Pharmacol; 1974 Jun; 23(12):1767-76. PubMed ID: 4841305
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of temperature on binding of warfarin by human serum albumin.
    Oester YT; Keresztes-Nagy S; Mais RF; Becktel J; Zaroslinski JF
    J Pharm Sci; 1976 Nov; 65(11):1673-7. PubMed ID: 994000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorimetric analysis of the binding of warfarin to human serum albumin. Equilibrium and kinetic study.
    Maes V; Engelborghs Y; Hoebeke J; Maras Y; Vercruysse A
    Mol Pharmacol; 1982 Jan; 21(1):100-7. PubMed ID: 7132952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bilirubin-albumin binding in neonatal salicylate intoxication.
    Ahlfors CE; Shwer ML; Ford KB
    Dev Pharmacol Ther; 1982; 4(1-2):47-60. PubMed ID: 7117090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relations between high-affinity binding sites for L-tryptophan, diazepam, salicylate and Phenol Red on human serum albumin.
    Kragh-Hansen U
    Biochem J; 1983 Jan; 209(1):135-42. PubMed ID: 6847607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of tolmetin and salicylic acid to human serum albumin as a function of temperature.
    Behm HL; Flynn GL; Wagner JG
    Biopharm Drug Dispos; 1981; 2(3):235-44. PubMed ID: 7295880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood binding of selezen (imidazole salicylate) in man.
    Zini R; Morin D; Acuto GC; Bianchini C; de Santis F; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1991 Jun; 29(6):242-9. PubMed ID: 1869346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circular dichroic investigations of the binding of salicylate and related compounds to human serum albumin.
    Otagiri M; Perrin JH
    Biochem Pharmacol; 1977 Feb; 26(4):283-8. PubMed ID: 849317
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanistic investigation on binding interaction of bioactive imidazole with protein bovine serum albumin--a biophysical study.
    Jayabharathi J; Thanikachalam V; Venkatesh Perumal M
    Spectrochim Acta A Mol Biomol Spectrosc; 2011 Aug; 79(3):502-7. PubMed ID: 21507709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of salicylate between neonatal and maternal serum at diffusion equilibrium.
    Levy G; Procknal JA; Garrettson LK
    Clin Pharmacol Ther; 1975 Aug; 18(2):210-4. PubMed ID: 1157445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of imidazole derivatives and the spectral characterization of the binding properties towards human serum albumin.
    Yue Y; Dong Q; Zhang Y; Li X; Yan X; Sun Y; Liu J
    Spectrochim Acta A Mol Biomol Spectrosc; 2016 Jan; 153():688-703. PubMed ID: 26474241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Theoretical analysis of the binding of salicylate by human serum albumin: the relationship between free and bound drug and therapeutic levels.
    Wosilait WD
    Eur J Clin Pharmacol; 1976 Feb; 9(4):285-90. PubMed ID: 971712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased protein binding of salicylates in Kawasaki disease.
    Koren G; Silverman E; Sundel R; Edney P; Newburger JW; Klein J; Robieux I; Laxer R; Giesbrecht E; Burns JC
    J Pediatr; 1991 Mar; 118(3):456-9. PubMed ID: 1999792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salsalate and salicylate binding to and their displacement of thyroxine from thyroxine-binding globulin, transthyrin, and albumin.
    Wang R; Nelson JC; Wilcox RB
    Thyroid; 1999 Apr; 9(4):359-64. PubMed ID: 10319941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma protein binding and interaction studies with diflunisal, a new salicylate analgesic.
    Verbeeck RK; Boel A; Buntinx A; De Schepper PJ
    Biochem Pharmacol; 1980 Feb; 29(4):571-6. PubMed ID: 7370051
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on interaction between an imidazole derivative and bovine serum by spectral methods.
    Jayabharathi J; Thanikachalam V; Venkatesh Perumal M
    Spectrochim Acta A Mol Biomol Spectrosc; 2012 Sep; 95():622-6. PubMed ID: 22584126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salicylate saturation index in neonatal jaundice.
    Seem E; Wille L
    Biol Neonate; 1975; 26(1-2):67-75. PubMed ID: 1148341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.